Modified polio vaccine helps fight deadly brain tumors
Duke Study: Poliovirus Therapy for Recurrent Glioblastoma Has 3-Year Survival Rate of 21% | Duke Department of Neurosurgery
Doctors say modified polio vaccine helps fight deadly brain tumors
Towards Immunotherapy for Pediatric Brain Tumors: Trends in Immunology
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Clinical Trial Studies Treating Brain Tumor with Genetically Modified Poliovirus | University Hospitals
Poliovirus therapy induces immune responses a | EurekAlert!
2016 Breast Cancer Highlight - Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer , Breast Cancer Research Program, Congressionally Directed Medical Research Programs
Poliovirus Therapy for Recurrent Glioblastoma has 3-Year Survival Rate of 21 Percent - Drug Discovery and Development
St. Lucie families cautious about cancer treatment 'breakthrough'
Poliovirus Therapy Shows Potential as Cancer Vaccine in Lab Studies | Duke Health
Poliovirus Therapy for Glioblastoma has Three-Year Survival Rate of 21 Percent | Duke Today
Frontiers | A Critical Overview of Targeted Therapies for Glioblastoma
Poliovirus therapy shows promise in patients with aggressive brain cancer
Cancers | Free Full-Text | Virus-Based Immunotherapy of Glioblastoma
Modified polio vaccine helps fight deadly brain tumors
Is polio the answer to curing brain tumors? | wkyc.com
Can the Polio Virus Kill Brain Tumors | University Hospitals
Frontiers | Current Options and Future Directions in Immune Therapy for Glioblastoma
Current state of immunotherapy for glioblastoma | Nature Reviews Clinical Oncology
Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
Polio vaccine may help those with glioblastoma | WPEC
